Intrust Bank’s Acura Pharmaceuticals ACUR Stock Holding History

Intrust Bank’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,792	Closed	-$24K	–	287
2015 Q2	$24K	Hold	4,792	–	–	0.01%	266
2015 Q1	$19K	Hold	4,792	–	–	0.01%	257
2014 Q4	$11K	Hold	4,792	–	–	﹤0.01%	259
2014 Q3	$19K	Hold	4,792	–	–	0.01%	252
2014 Q2	$26K	Hold	4,792	–	–	0.01%	269
2014 Q1	$35K	Buy	+4,792	New	+$41.6K	0.01%	270

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Intrust Bank's ACUR Position: Q3 2015 in Review

Intrust Bank sold out of Acura Pharmaceuticals (ACUR) in Q3 2015, closing a stake of 4,792 shares — an estimated $24K sold.

Intrust Bank first reported a position in ACUR in Q1 2014 and held it in 6 quarters. The position peaked at $35K in Q1 2014. 22 funds tracked by Wall St. Rank hold ACUR as of Q3 2015.

Intrust Bank reported no remaining Acura Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Intrust Bank sold 4,792 Acura Pharmaceuticals shares in Q3 2015, an estimated $24K.
Intrust Bank first reported a position in Acura Pharmaceuticals in Q1 2014 and held it in 6 quarters.
Intrust Bank's Acura Pharmaceuticals position peaked at $35K in Q1 2014.
22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2015.

Based on Intrust Bank's 13F filing for Q3 2015, filed 4 Nov 2015.